Patent Assignment
Reel/Frame 049363/0706
Release of Security Interest
Recorded: 2019-06-04
Pages: 31
Assignor
CORTLAND CAPITAL MARKET SERVICES LLC
Executed: 2019-05-29
Assignee
CEMPRA PHARMACEUTICALS, INC.
44 WHIPPANY ROAD, 2ND FLOOR, MORRISTOWN, NEW JERSEY, 07960
Covered Properties
(29)
Triazole-Containing Macrolides and Ophthalmic Uses Therefor
PCT:
PCT/US2018/018523 ↗
Compositions and Methods for Treating Dry Eye Diseases
PCT:
PCT/US2018/021304 ↗
Process for the Preparation of Macrolide Antibacterial Agents
Biodefenses Using Triazole-Containing Macrolides
Methods for Treating Gastrointestinal Diseases
Methods for Treating Resistant Diseases Using Triazole Containing Macrolides
Methods for Treating Malaria, Tuberculosis and Mac Diseases
Compounds and Methods for Treating Inflammatory Diseases
Patent:
9,937,194 →
Application:
13/596,875 →
Crystalline Forms of a Macrolide, and Uses Therefor
Process for Preparing Triazole-Containing Ketolide Antibiotics
Hydrogen Bond Forming Fluoro Ketolides for Treating Diseases
Crystalline Forms of a Macrolide, and Uses Therefor
Methods for Treating Gastrointestinal Diseases
Methods for Treating Resistant Diseases Using Triazole Containing Macrolides
Parenteral Formulations for Administering Macrolide Antibiotics
Biodefenses Using Triazole-Containing Macrolides
Methods for Treating Respiratory Diseases and Formulations Therefor
Convergent Processes for Preparing Macrolide Antibacterial Agents
Process for the Preparation of Macrolide Antibacterial Agents
Processes for Preparing Fluoroketolides
Application:
15/555,701 →
Publication:
US 2018/0044365
Methods for Treating Resistant Diseases Using Triazole Containing Macrolides
Application:
15/875,187 →
Publication:
US 2018/0369262
Convergent Processes for Preparing Macrolide Antibacterial Agents
Application:
15/899,844 →
Publication:
US 2019/0023731
Crystalline Forms of a Macrolide, and Uses Therefor
Application:
15/904,826 →
Publication:
US 2019/0040096
Compounds and Methods for Treating Inflammatory Diseases
Application:
15/904,882 →
Publication:
US 2019/0038653
Processes for Preparing Macrolides and Ketolides and Intermediates Therefor
Application:
15/913,650 →
Publication:
US 2019/0048035
Parenteral Formulations of Macrolide Antibiotics
Application:
15/918,098 →
Publication:
US 2019/0054059
Powder Oral Suspension Formulations of Antibacterial Agents
Application:
16/130,217 →
Publication:
US 2019/0209530
Process for the Preparation of Macrolide Antibacterial Agents
Application:
16/155,939 →
Publication:
US 2019/0241602
Parenteral Formulations for Administering Macrolide Antibiotics
Application:
16/205,445 →
Publication:
US 2019/0328759
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Assignment of Assignor's Interest
Apr 4, 2018
From: FERNANDES, PRABHAVATHI
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 045431/0285 →
Security Interest
Jul 25, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; MELINTA SUBSIDIARY CORP.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 046454/0392 →
Assignment of Assignor's Interest
Aug 14, 2019
From: CEMPRA PHARMACEUTICALS, INC.
To: TETARD, INC.
Reel/Frame 050056/0731 →